Dong-Young Son
Corporate Officer/Principal bei Pai Chai University
Aktive Positionen von Dong-Young Son
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Pai Chai University | Corporate Officer/Principal | 01.03.2013 | - |
Karriereverlauf von Dong-Young Son
Ehemalige bekannte Positionen von Dong-Young Son
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SPHERE POWER INC. | Direktor/Vorstandsmitglied | 17.09.2015 | - |
| Independent Dir/Board Member | 17.09.2015 | - | |
KB No. 3 Special Purpose Acquistion Co.
 KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Direktor/Vorstandsmitglied | 17.09.2015 | - |
| Independent Dir/Board Member | 17.09.2015 | - |
Ausbildung von Dong-Young Son
| Seoul National University | Undergraduate Degree |
| Konkuk University | Graduate Degree |
Statistik
International
| Südkorea | 6 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 4 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPHERE POWER INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
KB No. 3 Special Purpose Acquistion Co.
KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Finance |
- Börse
- Insiders
- Dong-Young Son
- Erfahrung
